SHANGHAI BIOSMELT PHARMA CO. LTD
Overview
SHANGHAI BIOSMELT PHARMA CO. LTD is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering HUMAN UMBILICAL CORD MESENCHYMAL STEM CELL-DERIVED EXOSOMES.
API / Drug Master Files
SHANGHAI BIOSMELT PHARMA CO. LTD holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- HUMAN UMBILICAL CORD MESENCHYMAL STEM CELL-DERIVED EXOSOMESActive2025-10-11
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to SHANGHAI BIOSMELT PHARMA CO. LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this SHANGHAI BIOSMELT PHARMA CO. LTD? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.